PATENT CLAIM ANALYSIS

Application Number: 16034710
Application Type: Utility
Filing Date: 2018-07
Publication Date: 2018-11
Patent Classification: ["514", "055000"]

Abstract:
A task of the invention is to provide an art that inhibits the hemorrhagic activity exhibited by sulfated glycosaminoglycans, as well as a material, a medical material, and a drug that use a sulfated glycosaminoglycan while being free of the hemorrhaging problems caused by sulfated glycosaminoglycans and that can exhibit an excellent therapeutic effect on biological tissues. The present invention relates to an inhibitor of the hemorrhagic activity originating from sulfated glycosaminoglycans, the inhibitor having a cationized chitosan as an active ingredient.

Claim (Index 1):
A method for dressing a wound, the method comprising:\n covering the wound with a complex comprising a quaternary chitosan and a sulfated glycosaminoglycan selected from the group consisting of a heparin and a chondroitin sulfate, wherein the quaternary chitosan is a chitosan molecule to which a C 1-4  alkyl ammonium group is covalently bonded at an amino group of the chitosan molecule.

Metadata:
- Claim Count in Document: 15.0
- Percentile: 95.0
- Lexical Diversity: 1.62963
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['11803404', '09727873', '12659656', '13823437', '11171490']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7056726939887888
- 35 USC 102 Novelty (BERT): 0.4988838979174282
- Combined Prediction Score: 0.6849938143816527
- Mean Citation Score: 189.527132
- Max Citation Score: 216.40805
- Similarity Product: 154.0529828459233

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test